Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 83Glioma 73Glioblastoma 73Neuroblastoma 27Neoplasms 22Astrocytoma 20Neurofibromatosis 1 19Ependymoma 19Sarcoma 18Medulloblastoma 18Central Nervous System Neoplasms 18Rhabdoid Tumor 15Melanoma 15Meningioma 14Carcinoma, Non-Small-Cell Lung 14Osteosarcoma 13Wilms Tumor 12Sarcoma, Ewing 12Rhabdomyosarcoma 12Breast Neoplasms 12Neurofibroma, Plexiform 11Hepatoblastoma 11Diffuse Intrinsic Pontine Glioma 10Neuroectodermal Tumors, Primitive, Peripheral 9Lymphoma, Non-Hodgkin 9Histiocytosis, Langerhans-Cell 9Thyroid Neoplasms 8Recurrence 8Pancreatic Neoplasms 8Neoplasm Metastasis 8

Interventions

Temozolomide 1Radiotherapy, Intensity-Modulated 1Mycophenolic Acid 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Glioblastoma × CNS × 30 days × Clear all
NCT07605364 2026-05-26

Testing the Addition of an Anti-Cancer Drug, Mycophenolate Mofetil, to the Usual Treatment (Radiation Therapy and Temozolomide) for Advanced Brain Cancer

Alliance for Clinical Trials in Oncology

Phase 2/3 Not yet recruiting
422 enrolled
CNS

Advanced Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡